25 XP   0   0   10

Zhejiang Yatai Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Yatai Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Yatai Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Yatai Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Yatai Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Yatai Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Yatai Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Yatai Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
95.0%

What is your share worth?

Current worth
¥0.68
Expected worth in 1 year
¥0.78
How sure are you?
67.5%

+ What do you gain per year?

Total Gains per Share
¥0.13
Return On Investment
3.6%

For what price can you sell your share?

Current Price per Share
¥3.52
Expected price per share
¥2.63 - ¥4.11
How sure are you?
50%

1. Valuation of Zhejiang Yatai Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥3.52

Intrinsic Value Per Share

¥-3.82 - ¥-4.59

Total Value Per Share

¥-3.14 - ¥-3.91

2. Growth of Zhejiang Yatai Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Yatai Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$57.1m$54.4m-$8.2m-17.9%

How much money is Zhejiang Yatai Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.7m-$7.4m$5.6m328.5%
Net Profit Margin-9.7%-61.2%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Yatai Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Yatai Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Yatai Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Yatai Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Yatai Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Yatai Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Yatai Pharmaceutical Co Ltd is ¥3.52. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Yatai Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Yatai Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥0.68. Based on the TTM, the Book Value Change Per Share is ¥0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Yatai Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.00-0.1%0.00-0.1%-0.01-0.3%-0.03-0.8%-0.01-0.3%
Usd Book Value Change Per Share0.020.6%0.000.1%-0.01-0.3%-0.02-0.7%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.1%
Usd Total Gains Per Share0.020.6%0.000.1%-0.01-0.3%-0.02-0.6%0.000.0%
Usd Price Per Share0.63-0.63-0.73-0.94-1.82-
Price to Earnings Ratio-37.69--73.15--25.00--30.82-60.68-
Price-to-Total Gains Ratio30.12-76.39--126.73--31.66-201.95-
Price to Book Ratio6.75-8.46-8.25-5.98-8.10-
Price-to-Total Gains Ratio30.12-76.39--126.73--31.66-201.95-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.487168
Number of shares2052
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.02
Usd Total Gains Per Share0.00-0.02
Gains per Quarter (2052 shares)9.11-45.81
Gains per Year (2052 shares)36.43-183.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18282610-193-193
216566220-386-376
325859829-579-559
43311313439-772-742
54114117049-965-925
64916920659-1158-1108
75719824268-1351-1291
86522627878-1544-1474
97425431488-1737-1657
108228235098-1930-1840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%24.016.00.060.0%34.016.05.061.8%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%25.015.00.062.5%34.021.00.061.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.00.02.095.0%49.00.06.089.1%
Total Gains per Share3.01.00.075.0%4.08.00.033.3%7.013.00.035.0%27.013.00.067.5%39.016.00.070.9%

Fundamentals of Zhejiang Yatai Pharmaceutical Co Ltd

About Zhejiang Yatai Pharmaceutical Co Ltd

Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers tablets, capsules, patches, powder injections, freeze-dried powders, and troches. It also provides pharmaceutical research and development services. The company was founded in 1989 and is based in Shaoxing, China.

Fundamental data was last updated by Penke on 2024-03-24 01:21:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Yatai Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Yatai Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Yatai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -22.9% means that ¥-0.23 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The MRQ is -22.9%. The company is making a huge loss. -2
  • The TTM is -9.7%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-22.9%TTM-9.7%-13.2%
TTM-9.7%YOY-61.2%+51.5%
TTM-9.7%5Y635.6%-645.4%
5Y635.6%10Y325.0%+310.6%
1.1.2. Return on Assets

Shows how efficient Zhejiang Yatai Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Yatai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.3% Return on Assets means that Zhejiang Yatai Pharmaceutical Co Ltd generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The MRQ is -1.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.3%TTM-0.8%-0.5%
TTM-0.8%YOY-3.4%+2.6%
TTM-0.8%5Y-5.5%+4.7%
5Y-5.5%10Y-2.0%-3.5%
1.1.3. Return on Equity

Shows how efficient Zhejiang Yatai Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Yatai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -4.5% Return on Equity means Zhejiang Yatai Pharmaceutical Co Ltd generated ¥-0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The MRQ is -4.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.5%TTM-3.9%-0.6%
TTM-3.9%YOY-13.1%+9.2%
TTM-3.9%5Y-20.4%+16.6%
5Y-20.4%10Y-9.2%-11.2%

1.2. Operating Efficiency of Zhejiang Yatai Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Yatai Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Yatai Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Yatai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -13.7% means the company generated ¥-0.14  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The MRQ is -13.7%. The company is operating very inefficient. -2
  • The TTM is -3.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-13.7%TTM-3.0%-10.7%
TTM-3.0%YOY-23.2%+20.3%
TTM-3.0%5Y645.7%-648.7%
5Y645.7%10Y323.9%+321.9%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Yatai Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.90 means that the operating costs are ¥1.90 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The MRQ is 1.899. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.690. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.899TTM1.690+0.209
TTM1.690YOY1.861-0.171
TTM1.6905Y1.122+0.567
5Y1.12210Y0.874+0.248

1.3. Liquidity of Zhejiang Yatai Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Yatai Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 6.45 means the company has ¥6.45 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The MRQ is 6.450. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.532. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.450TTM5.532+0.917
TTM5.532YOY5.670-0.138
TTM5.5325Y6.038-0.506
5Y6.03810Y3.275+2.764
1.3.2. Quick Ratio

Measures if Zhejiang Yatai Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Yatai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.90 means the company can pay off ¥0.90 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The MRQ is 0.895. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.746. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.895TTM0.746+0.149
TTM0.746YOY0.525+0.221
TTM0.7465Y0.848-0.102
5Y0.84810Y1.118-0.270

1.4. Solvency of Zhejiang Yatai Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Yatai Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Yatai Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.71 means that Zhejiang Yatai Pharmaceutical Co Ltd assets are financed with 70.8% credit (debt) and the remaining percentage (100% - 70.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The MRQ is 0.708. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.772. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.708TTM0.772-0.063
TTM0.772YOY0.745+0.026
TTM0.7725Y0.645+0.126
5Y0.64510Y0.425+0.220
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Yatai Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Yatai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 242.8% means that company has ¥2.43 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The MRQ is 2.428. The company is just not able to pay all its debts with equity.
  • The TTM is 3.486. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.428TTM3.486-1.058
TTM3.486YOY2.935+0.551
TTM3.4865Y2.305+1.181
5Y2.30510Y1.331+0.974

2. Market Valuation of Zhejiang Yatai Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Yatai Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Yatai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -37.69 means the investor is paying ¥-37.69 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The EOD is -28.967. Based on the earnings, the company is expensive. -2
  • The MRQ is -37.690. Based on the earnings, the company is expensive. -2
  • The TTM is -73.153. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-28.967MRQ-37.690+8.723
MRQ-37.690TTM-73.153+35.463
TTM-73.153YOY-24.997-48.156
TTM-73.1535Y-30.817-42.336
5Y-30.81710Y60.677-91.494
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The EOD is -74.055. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -96.356. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -76.005. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-74.055MRQ-96.356+22.301
MRQ-96.356TTM-76.005-20.351
TTM-76.005YOY-54.402-21.602
TTM-76.0055Y-62.065-13.940
5Y-62.06510Y-42.409-19.656
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Yatai Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Yatai Pharmaceutical Co Ltd:

  • The EOD is 5.190. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.753. Based on the equity, the company is overpriced. -1
  • The TTM is 8.463. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.190MRQ6.753-1.563
MRQ6.753TTM8.463-1.709
TTM8.463YOY8.249+0.214
TTM8.4635Y5.983+2.479
5Y5.98310Y8.105-2.121
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Yatai Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1510.025+508%-0.088+158%-0.170+212%-0.012+108%
Book Value Per Share--0.6780.547+24%0.645+5%1.501-55%1.953-65%
Current Ratio--6.4505.532+17%5.670+14%6.038+7%3.275+97%
Debt To Asset Ratio--0.7080.772-8%0.745-5%0.645+10%0.425+67%
Debt To Equity Ratio--2.4283.486-30%2.935-17%2.305+5%1.331+82%
Dividend Per Share--0.0010.007-89%0.007-87%0.009-91%0.017-95%
Eps---0.030-0.021-32%-0.088+190%-0.194+538%-0.072+138%
Free Cash Flow Per Share---0.0120.005-335%-0.029+142%-0.047+291%-0.040+239%
Free Cash Flow To Equity Per Share---0.013-0.015+16%-0.070+454%0.019-166%0.042-130%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.587--------
Intrinsic Value_10Y_min---3.820--------
Intrinsic Value_1Y_max---0.097--------
Intrinsic Value_1Y_min---0.095--------
Intrinsic Value_3Y_max---0.568--------
Intrinsic Value_3Y_min---0.536--------
Intrinsic Value_5Y_max---1.372--------
Intrinsic Value_5Y_min---1.249--------
Market Cap2144281948.160-30%2790003216.6402770205158.880+1%3230129269.920-14%4138707828.352-33%7996130943.760-65%
Net Profit Margin---0.229-0.097-58%-0.612+167%6.356-104%3.250-107%
Operating Margin---0.137-0.030-78%-0.232+70%6.457-102%3.239-104%
Operating Ratio--1.8991.690+12%1.861+2%1.122+69%0.874+117%
Pb Ratio5.190-30%6.7538.463-20%8.249-18%5.983+13%8.105-17%
Pe Ratio-28.967+23%-37.690-73.153+94%-24.997-34%-30.817-18%60.677-162%
Price Per Share3.520-30%4.5804.548+1%5.303-14%6.794-33%13.126-65%
Price To Free Cash Flow Ratio-74.055+23%-96.356-76.005-21%-54.402-44%-62.065-36%-42.409-56%
Price To Total Gains Ratio23.147-30%30.11876.388-61%-126.727+521%-31.655+205%201.952-85%
Quick Ratio--0.8950.746+20%0.525+70%0.848+6%1.118-20%
Return On Assets---0.013-0.008-37%-0.034+161%-0.055+323%-0.020+53%
Return On Equity---0.045-0.039-14%-0.131+192%-0.204+356%-0.092+105%
Total Gains Per Share--0.1520.032+374%-0.081+153%-0.161+206%0.005+2926%
Usd Book Value--57176519.77246154129.942+24%54403110.302+5%126572443.254-55%164656619.336-65%
Usd Book Value Change Per Share--0.0210.003+508%-0.012+158%-0.024+212%-0.002+108%
Usd Book Value Per Share--0.0940.076+24%0.089+5%0.208-55%0.270-65%
Usd Dividend Per Share--0.0000.001-89%0.001-87%0.001-91%0.002-95%
Usd Eps---0.004-0.003-32%-0.012+190%-0.027+538%-0.010+138%
Usd Free Cash Flow---1001848.028426654.001-335%-2427436.431+142%-3920425.894+291%-2972826.716+197%
Usd Free Cash Flow Per Share---0.0020.001-335%-0.004+142%-0.006+291%-0.006+239%
Usd Free Cash Flow To Equity Per Share---0.002-0.002+16%-0.010+454%0.003-166%0.006-130%
Usd Market Cap296768621.625-30%386136445.183383396393.989+1%447049890.957-14%572797163.444-33%1106664522.616-65%
Usd Price Per Share0.487-30%0.6340.629+1%0.734-14%0.940-33%1.817-65%
Usd Profit---2561249.375-1732609.337-32%-7423635.488+190%-16330545.828+538%-6090553.453+138%
Usd Revenue--11171703.20215263936.372-27%11454455.316-2%17754023.081-37%22178859.856-50%
Usd Total Gains Per Share--0.0210.004+374%-0.011+153%-0.022+206%0.001+2926%
 EOD+2 -6MRQTTM+18 -17YOY+28 -75Y+18 -1710Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Yatai Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-28.967
Price to Book Ratio (EOD)Between0-15.190
Net Profit Margin (MRQ)Greater than0-0.229
Operating Margin (MRQ)Greater than0-0.137
Quick Ratio (MRQ)Greater than10.895
Current Ratio (MRQ)Greater than16.450
Debt to Asset Ratio (MRQ)Less than10.708
Debt to Equity Ratio (MRQ)Less than12.428
Return on Equity (MRQ)Greater than0.15-0.045
Return on Assets (MRQ)Greater than0.05-0.013
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Yatai Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.908
Ma 20Greater thanMa 503.555
Ma 50Greater thanMa 1003.574
Ma 100Greater thanMa 2004.079
OpenGreater thanClose3.470
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,416,331
Total Liabilities1,003,206
Total Stockholder Equity413,125
 As reported
Total Liabilities 1,003,206
Total Stockholder Equity+ 413,125
Total Assets = 1,416,331

Assets

Total Assets1,416,331
Total Current Assets928,209
Long-term Assets488,123
Total Current Assets
Cash And Cash Equivalents 705,495
Net Receivables 128,836
Inventory 74,378
Other Current Assets 19,500
Total Current Assets  (as reported)928,209
Total Current Assets  (calculated)928,209
+/- 0
Long-term Assets
Property Plant Equipment 363,290
Intangible Assets 72,990
Other Assets 25,708
Long-term Assets  (as reported)488,123
Long-term Assets  (calculated)461,988
+/- 26,134

Liabilities & Shareholders' Equity

Total Current Liabilities143,911
Long-term Liabilities859,295
Total Stockholder Equity413,125
Total Current Liabilities
Short Long Term Debt 50,054
Accounts payable 45,246
Other Current Liabilities 41,540
Total Current Liabilities  (as reported)143,911
Total Current Liabilities  (calculated)136,840
+/- 7,071
Long-term Liabilities
Long term Debt 811,494
Other Liabilities 47,801
Long-term Liabilities Other 38,044
Deferred Long Term Liability 13,906
Long-term Liabilities  (as reported)859,295
Long-term Liabilities  (calculated)911,245
+/- 51,949
Total Stockholder Equity
Common Stock564,440
Other Stockholders Equity 178,771
Total Stockholder Equity (as reported)413,125
Total Stockholder Equity (calculated)743,211
+/- 330,086
Other
Capital Stock564,440
Common Stock Shares Outstanding 564,440
Net Debt 156,054
Net Invested Capital 1,274,674
Net Tangible Assets 353,769
Net Working Capital 784,298
Property Plant and Equipment Gross 363,290



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-31
> Total Assets 
441,873
865,853
841,944
839,320
864,978
878,797
860,524
822,268
871,784
851,385
853,399
857,876
818,018
775,611
765,492
765,846
801,862
782,084
786,450
791,358
848,528
897,195
897,893
900,486
2,060,949
1,954,089
1,933,801
2,665,945
2,470,697
2,544,899
2,564,365
2,587,532
2,738,064
2,970,623
3,225,849
3,241,266
3,297,227
3,583,515
4,459,541
4,423,602
2,268,340
2,262,775
2,181,185
1,799,585
1,956,321
1,946,644
1,775,749
1,740,745
1,610,781
1,561,546
1,470,251
1,521,037
1,523,621
1,491,228
1,432,633
1,416,331
1,416,3311,432,6331,491,2281,523,6211,521,0371,470,2511,561,5461,610,7811,740,7451,775,7491,946,6441,956,3211,799,5852,181,1852,262,7752,268,3404,423,6024,459,5413,583,5153,297,2273,241,2663,225,8492,970,6232,738,0642,587,5322,564,3652,544,8992,470,6972,665,9451,933,8011,954,0892,060,949900,486897,893897,195848,528791,358786,450782,084801,862765,846765,492775,611818,018857,876853,399851,385871,784822,268860,524878,797864,978839,320841,944865,853441,873
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,451,254
1,350,859
1,247,077
1,397,688
2,179,622
2,108,524
1,482,119
1,475,508
1,398,843
1,023,842
1,274,838
1,264,955
1,071,369
1,060,316
995,849
962,755
887,333
951,415
1,004,845
978,313
938,286
928,209
928,209938,286978,3131,004,845951,415887,333962,755995,8491,060,3161,071,3691,264,9551,274,8381,023,8421,398,8431,475,5081,482,1192,108,5242,179,6221,397,6881,247,0771,350,8591,451,2540000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
822,373
648,917
534,500
547,450
1,332,654
1,269,274
1,180,245
1,174,242
1,144,063
807,929
902,935
943,585
812,571
850,783
821,113
798,692
709,631
732,455
757,617
739,005
710,867
705,495
705,495710,867739,005757,617732,455709,631798,692821,113850,783812,571943,585902,935807,9291,144,0631,174,2421,180,2451,269,2741,332,654547,450534,500648,917822,3730000000000000000000000000000000000
       Net Receivables 
123,311
105,861
91,409
102,770
131,242
137,229
110,576
137,479
137,808
131,578
125,930
144,845
135,134
138,416
118,007
103,207
129,768
146,147
157,317
130,408
170,866
225,216
212,082
203,691
261,083
320,784
315,659
297,395
327,367
303,273
311,284
332,450
325,164
376,312
382,433
391,339
434,300
507,842
472,076
440,390
98,230
117,033
101,927
99,342
277,060
189,439
165,019
125,913
86,424
69,067
95,054
91,432
130,792
127,732
129,401
128,836
128,836129,401127,732130,79291,43295,05469,06786,424125,913165,019189,439277,06099,342101,927117,03398,230440,390472,076507,842434,300391,339382,433376,312325,164332,450311,284303,273327,367297,395315,659320,784261,083203,691212,082225,216170,866130,408157,317146,147129,768103,207118,007138,416135,134144,845125,930131,578137,808137,479110,576137,229131,242102,77091,409105,861123,311
       Other Current Assets 
2,818
19,529
21,452
37,365
7,093
12,507
14,793
12,978
4,732
23,859
11,500
4,516
3,090
6,684
4,474
6,249
3,053
3,308
7,905
11,836
1,838
5,697
9,727
4,505
13,203
44,876
11,485
11,543
29,570
58,085
62,841
72,906
57,849
109,528
89,143
154,683
107,577
43,960
58,292
61,648
48,959
47,586
34,707
30,892
29,966
38,727
29,990
32,136
27,413
26,459
23,341
43,382
21,231
18,260
17,088
19,500
19,50017,08818,26021,23143,38223,34126,45927,41332,13629,99038,72729,96630,89234,70747,58648,95961,64858,29243,960107,577154,68389,143109,52857,84972,90662,84158,08529,57011,54311,48544,87613,2034,5059,7275,6971,83811,8367,9053,3083,0536,2494,4746,6843,0904,51611,50023,8594,73212,97814,79312,5077,09337,36521,45219,5292,818
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,185,827
2,279,919
2,315,078
786,221
787,267
782,343
775,743
681,483
681,689
704,381
680,429
614,933
598,791
582,918
569,622
518,776
512,914
494,347
488,123
488,123494,347512,914518,776569,622582,918598,791614,933680,429704,381681,689681,483775,743782,343787,267786,2212,315,0782,279,9192,185,8270000000000000000000000000000000000000
       Property Plant Equipment 
187,947
168,636
192,424
173,517
250,134
228,944
258,430
239,607
272,564
249,069
275,181
257,007
285,823
268,575
287,675
262,861
281,493
269,469
267,163
284,598
290,488
291,069
294,358
294,829
298,006
297,763
315,591
314,634
341,280
350,118
356,177
385,541
596,462
606,273
692,994
765,112
845,856
926,942
1,038,312
1,044,354
595,934
593,998
585,467
576,330
487,747
482,729
473,581
466,716
433,991
424,830
415,266
408,019
385,890
378,687
370,086
363,290
363,290370,086378,687385,890408,019415,266424,830433,991466,716473,581482,729487,747576,330585,467593,998595,9341,044,3541,038,312926,942845,856765,112692,994606,273596,462385,541356,177350,118341,280314,634315,591297,763298,006294,829294,358291,069290,488284,598267,163269,469281,493262,861287,675268,575285,823257,007275,181249,069272,564239,607258,430228,944250,134173,517192,424168,636187,947
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,086
16,086
16,086
9,497
9,497
9,497
9,497
676,888
676,888
676,888
676,888
670,395
670,395
670,395
670,395
670,395
670,395
670,395
670,395
670,395
670,395
670,395
670,395
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000670,395670,395670,395670,395670,395670,395670,395670,395670,395670,395670,395670,395676,888676,888676,888676,8889,4979,4979,4979,49716,08616,08616,08600000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,985
34,159
33,852
34,539
28,640
65,493
79,870
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000079,87065,49328,64034,53933,85234,15933,9850000000000000000000000000000000000
       Intangible Assets 
0
23,423
0
23,147
0
22,872
0
22,596
0
22,320
0
38,130
0
37,854
0
37,578
0
37,303
63,369
63,100
56,242
55,973
62,611
62,307
760,679
770,176
768,622
766,728
758,315
756,518
753,955
752,122
751,899
749,914
104,757
101,171
239,944
201,908
155,275
216,323
102,517
105,866
109,937
112,743
112,739
118,463
120,216
122,025
118,665
118,114
117,495
117,475
76,843
75,693
74,413
72,990
72,99074,41375,69376,843117,475117,495118,114118,665122,025120,216118,463112,739112,743109,937105,866102,517216,323155,275201,908239,944101,171104,757749,914751,899752,122753,955756,518758,315766,728768,622770,176760,67962,30762,61155,97356,24263,10063,36937,303037,578037,854038,130022,320022,596022,872023,147023,4230
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
301,853
285,954
257,314
43,072
43,255
43,287
576,330
487,747
0
0
0
0
0
0
0
227
0
0
0
0002270000000487,747576,33043,28743,25543,072257,314285,954301,8530000000000000000000000000000000000000
> Total Liabilities 
212,083
179,050
149,823
135,493
145,024
142,146
114,131
83,423
126,484
101,421
129,540
140,220
114,078
75,919
69,274
65,622
92,036
58,073
57,944
56,425
101,213
134,001
136,897
130,054
1,267,795
1,138,748
1,097,929
511,055
275,754
303,058
295,767
269,126
368,791
535,139
778,186
758,140
773,073
1,002,659
1,717,078
1,714,528
1,635,280
1,654,344
1,602,070
1,272,970
1,295,912
1,309,566
1,158,541
1,174,671
1,177,820
1,156,637
1,088,309
1,168,505
1,222,400
1,192,626
1,111,646
1,003,206
1,003,2061,111,6461,192,6261,222,4001,168,5051,088,3091,156,6371,177,8201,174,6711,158,5411,309,5661,295,9121,272,9701,602,0701,654,3441,635,2801,714,5281,717,0781,002,659773,073758,140778,186535,139368,791269,126295,767303,058275,754511,0551,097,9291,138,7481,267,795130,054136,897134,001101,21356,42557,94458,07392,03665,62269,27475,919114,078140,220129,540101,421126,48483,423114,131142,146145,024135,493149,823179,050212,083
   > Total Current Liabilities 
211,925
178,805
149,703
135,282
144,794
141,901
113,853
83,226
126,333
101,235
129,262
139,910
113,807
75,606
68,992
65,289
91,694
57,722
57,562
55,869
100,133
132,708
135,404
128,950
752,929
617,590
583,429
509,554
274,369
301,749
294,322
267,706
267,503
226,938
290,629
258,348
289,261
369,354
262,503
245,571
173,376
175,174
149,632
143,703
291,519
294,435
237,367
244,088
214,150
192,947
113,143
182,996
222,383
194,283
153,168
143,911
143,911153,168194,283222,383182,996113,143192,947214,150244,088237,367294,435291,519143,703149,632175,174173,376245,571262,503369,354289,261258,348290,629226,938267,503267,706294,322301,749274,369509,554583,429617,590752,929128,950135,404132,708100,13355,86957,56257,72291,69465,28968,99275,606113,807139,910129,262101,235126,33383,226113,853141,901144,794135,282149,703178,805211,925
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,600
0
24,200
60,000
40,000
40,000
65,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000065,00040,00040,00060,00024,20008,6000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,600
0
24,200
60,000
40,000
40,000
65,000
0
0
0
0
0
0
0
0
0
30,000
80,000
50,061
50,085
50,054
50,054
50,05450,05450,08550,06180,00030,00000000000065,00040,00040,00060,00024,20008,6000000000000000000000000000000000000
       Accounts payable 
66,274
65,307
49,835
46,052
71,571
63,852
47,756
44,559
54,821
48,134
54,896
84,960
80,803
43,124
50,012
42,032
45,614
45,474
45,348
40,109
83,323
115,220
121,622
114,911
343,794
251,865
230,367
181,076
163,261
169,034
155,518
106,141
141,212
113,362
158,940
116,922
104,646
182,776
137,938
113,467
47,023
66,222
31,123
23,949
44,955
58,286
33,602
36,148
53,926
38,294
40,635
49,644
89,831
89,650
47,146
45,246
45,24647,14689,65089,83149,64440,63538,29453,92636,14833,60258,28644,95523,94931,12366,22247,023113,467137,938182,776104,646116,922158,940113,362141,212106,141155,518169,034163,261181,076230,367251,865343,794114,911121,622115,22083,32340,10945,34845,47445,61442,03250,01243,12480,80384,96054,89648,13454,82144,55947,75663,85271,57146,05249,83565,30766,274
       Other Current Liabilities 
14,551
23,498
9,868
9,230
5,223
10,049
8,097
10,667
13,512
13,101
4,366
2,890
13,004
12,482
8,980
13,257
16,080
12,247
12,214
15,760
16,811
17,489
13,782
14,039
170,386
145,726
126,312
108,420
111,108
112,715
98,804
121,565
86,291
98,576
63,461
82,239
58,509
51,200
28,500
28,500
40,059
34,259
28,006
34,689
137,025
143,651
26,753
34,040
34,832
34,650
24,585
43,374
68,705
45,437
43,861
41,540
41,54043,86145,43768,70543,37424,58534,65034,83234,04026,753143,651137,02534,68928,00634,25940,05928,50028,50051,20058,50982,23963,46198,57686,291121,56598,804112,715111,108108,420126,312145,726170,38614,03913,78217,48916,81115,76012,21412,24716,08013,2578,98012,48213,0042,8904,36613,10113,51210,6678,09710,0495,2239,2309,86823,49814,551
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
633,305
1,454,575
1,468,957
1,461,904
1,479,170
1,452,438
1,129,267
1,004,393
1,015,131
921,174
930,582
963,670
963,690
975,166
985,509
1,000,017
998,343
958,478
859,295
859,295958,478998,3431,000,017985,509975,166963,690963,670930,582921,1741,015,1311,004,3931,129,2671,452,4381,479,1701,461,9041,468,9571,454,575633,3050000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
561
545
530
514
755
732
710
688
665
643
916
884
100,902
302,929
306,757
310,393
319,212
322,705
427,131
431,674
479,958
487,576
492,159
159,091
73,954
73,777
83,206
80,876
100,752
99,541
98,441
97,236
100,002
100,196
47,589
47,801
47,80147,589100,196100,00297,23698,44199,541100,75280,87683,20673,77773,954159,091492,159487,576479,958431,674427,131322,705319,212310,393306,757302,929100,90288491664366568871073275551453054556100000100000010000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
123,769
117,458
174,715
179,785
181,674
177,246
52,696
55,853
59,787
62,454
68,649
74,341
76,064
76,184
71,101
70,707
70,244
70,747
22,143
19,634
13,946
13,906
13,90613,94619,63422,14370,74770,24470,70771,10176,18476,06474,34168,64962,45459,78755,85352,696177,246181,674179,785174,715117,458123,7690000000000000000000000000000000000
> Total Stockholder Equity
229,790
686,803
692,121
703,827
719,953
736,651
746,393
738,845
745,300
749,964
723,859
717,656
703,940
699,691
696,219
700,224
709,826
724,011
728,505
734,933
747,315
763,193
760,996
770,432
785,767
807,504
827,535
2,146,349
2,185,577
2,232,038
2,259,281
2,308,259
2,359,016
2,424,431
2,435,988
2,471,357
2,512,311
2,569,103
2,730,555
2,697,224
633,060
608,431
579,115
526,615
660,409
637,078
617,209
566,074
432,962
404,908
381,942
352,532
301,220
298,601
320,987
413,125
413,125320,987298,601301,220352,532381,942404,908432,962566,074617,209637,078660,409526,615579,115608,431633,0602,697,2242,730,5552,569,1032,512,3112,471,3572,435,9882,424,4312,359,0162,308,2592,259,2812,232,0382,185,5772,146,349827,535807,504785,767770,432760,996763,193747,315734,933728,505724,011709,826700,224696,219699,691703,940717,656723,859749,964745,300738,845746,393736,651719,953703,827692,121686,803229,790
   Common Stock
90,000
120,000
120,000
120,000
120,000
120,000
120,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
204,000
268,247
268,247
268,247
268,247
536,495
536,495
536,495
536,494
536,494
536,494
536,494
536,494
536,494
536,508
536,522
536,534
536,545
536,558
536,602
536,610
536,614
536,618
536,674
536,681
536,684
536,687
536,687
536,687
564,440
564,440536,687536,687536,687536,684536,681536,674536,618536,614536,610536,602536,558536,545536,534536,522536,508536,494536,494536,494536,494536,494536,494536,495536,495536,495268,247268,247268,247268,247204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000204,000120,000120,000120,000120,000120,000120,00090,000
   Retained Earnings 
107,908
122,424
128,455
139,638
145,750
162,366
171,921
164,835
167,084
171,548
144,922
138,535
125,046
120,559
117,266
120,977
129,846
175,706
180,021
185,470
198,058
212,639
209,223
220,778
233,157
257,359
276,744
298,290
338,048
384,812
412,830
461,769
513,375
578,868
591,075
626,297
667,511
665,093
621,715
588,384
-1,415,388
-1,440,196
-1,469,675
-1,522,325
-1,388,113
-1,412,055
-1,432,025
-1,483,222
-1,616,394
-1,645,265
-1,668,324
-1,697,778
-1,749,114
-1,751,733
-1,729,348
-1,747,854
-1,747,854-1,729,348-1,751,733-1,749,114-1,697,778-1,668,324-1,645,265-1,616,394-1,483,222-1,432,025-1,412,055-1,388,113-1,522,325-1,469,675-1,440,196-1,415,388588,384621,715665,093667,511626,297591,075578,868513,375461,769412,830384,812338,048298,290276,744257,359233,157220,778209,223212,639198,058185,470180,021175,706129,846120,977117,266120,559125,046138,535144,922171,548167,084164,835171,921162,366145,750139,638128,455122,424107,908
   Capital Surplus 00000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,462
1,610
1,349
0
204,830
204,830
204,784
204,735
204,694
204,655
204,011
203,859
203,834
203,818
203,804
203,610
203,588
203,577
203,572
203,572
203,572
178,771
178,771203,572203,572203,572203,577203,588203,610203,804203,818203,834203,859204,011204,655204,694204,735204,784204,830204,83001,3491,6101,4620000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue441,154
Cost of Revenue-287,697
Gross Profit153,457153,457
 
Operating Income (+$)
Gross Profit153,457
Operating Expense-442,369
Operating Income-1,215-288,912
 
Operating Expense (+$)
Research Development29,067
Selling General Administrative89,389
Selling And Marketing Expenses-
Operating Expense442,369118,456
 
Net Interest Income (+$)
Interest Income8,505
Interest Expense-51,112
Other Finance Cost-5,237
Net Interest Income-37,370
 
Pretax Income (+$)
Operating Income-1,215
Net Interest Income-37,370
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-49,569-1,215
EBIT - interestExpense = -51,112
-50,075
1,036
Interest Expense51,112
Earnings Before Interest and Taxes (EBIT)-1,543
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-49,569
Tax Provision-506
Net Income From Continuing Ops-50,075-50,075
Net Income-50,075
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-37,370
 

Technical Analysis of Zhejiang Yatai Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Yatai Pharmaceutical Co Ltd. The general trend of Zhejiang Yatai Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Yatai Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Yatai Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.89 < 4 < 4.11.

The bearish price targets are: 3.31 > 3.3 > 2.63.

Tweet this
Zhejiang Yatai Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Yatai Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Yatai Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Yatai Pharmaceutical Co Ltd. The current macd is 0.02528685.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Yatai Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zhejiang Yatai Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zhejiang Yatai Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zhejiang Yatai Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Yatai Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Yatai Pharmaceutical Co Ltd. The current adx is 28.90.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Yatai Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Zhejiang Yatai Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Yatai Pharmaceutical Co Ltd. The current sar is 3.94708224.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Yatai Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Yatai Pharmaceutical Co Ltd. The current rsi is 46.91. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Zhejiang Yatai Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Yatai Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Yatai Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Yatai Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Yatai Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Yatai Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Yatai Pharmaceutical Co Ltd. The current cci is -24.03343783.

Zhejiang Yatai Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Yatai Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Yatai Pharmaceutical Co Ltd. The current cmo is -11.81659237.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Yatai Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Yatai Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Yatai Pharmaceutical Co Ltd. The current willr is -72.72727273.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zhejiang Yatai Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhejiang Yatai Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Yatai Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Yatai Pharmaceutical Co Ltd.

Zhejiang Yatai Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Yatai Pharmaceutical Co Ltd. The current atr is 0.16297043.

Zhejiang Yatai Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Yatai Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Yatai Pharmaceutical Co Ltd. The current obv is 928,101,945.

Zhejiang Yatai Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Yatai Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Yatai Pharmaceutical Co Ltd. The current mfi is 53.40.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Yatai Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Yatai Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Yatai Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Zhejiang Yatai Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Yatai Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.908
Ma 20Greater thanMa 503.555
Ma 50Greater thanMa 1003.574
Ma 100Greater thanMa 2004.079
OpenGreater thanClose3.470
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Yatai Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Yatai Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Yatai Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Yatai Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Yatai Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Yatai Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Yatai Pharmaceutical Co Ltd in your mailbox!